kasugamycin has been researched along with Aging in 1 studies
*Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akosman, B; El-Deiry, WS; Elias, JA; He, CH; Huntington, K; Kamle, S; Kang, MJ; Lee, CG; Lee, CM; Liang, O; Ma, B; Machan, JT; Mizoguchi, E; Shin, HJ; Zhou, Y | 1 |
1 other study(ies) available for kasugamycin and Aging
| Article | Year |
|---|---|
Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19.
Topics: Aging; Aminoglycosides; Angiotensin-Converting Enzyme 2; Cell Line, Tumor; Chitinase-3-Like Protein 1; COVID-19; COVID-19 Drug Treatment; HEK293 Cells; Humans; SARS-CoV-2 | 2021 |